8 related news articles for Hormone Cancer Therapeutics

For Associate Professor Simon Chu, the problem leading Hudson Institute’s research into rare ovarian cancers was getting access to large quantities of real-world data, and the solution came from a surprising place: social media.…  Read more

Jessica Clark calls herself the luckiest unlucky person in the world – but she still wants to know why she got ovarian cancer at such a young age.…  Read more

When it comes to rare forms of cancer, researchers and patients share the same problem – finding enough information from which to make informed decisions.…  Read more

Ovarian cancer specialists have taken a novel path to advance their research – tapping into an international Facebook group to learn from members’ experiences.…  Read more

Not even Covid-19 could stop a pioneer in the fight against rare ovarian cancers finishing his epic fundraising ride. In early May Dr Simon Chu took a break from the lab and put rubber on the road in the Ride4Research, aiming to cover 900km in 9 days from Canberra to Melbourne.…  Read more

A pioneer in the fight against rare ovarian cancers is taking a break from the lab and putting rubber on the road as part of the Ride4Research.…  Read more

A double-barrelled, non-surgical method to treat a rare type of ovarian cancer may provide hope for many patients.…  Read more

A new study has identified a genetic mutation that could be linked to an aggressive type of ovarian cancer driven by hormones. A team of scientists at Hudson Institute of Medical Research, with collaborators at the Peter MacCallum Cancer Centre and the University of Western Australia, used large-scale genome sequencing to map the tumour genome…  Read more